ArticleAmerican journal of translational research2025
A predictive model for anlotinib-osimertinib efficacy in advanced non-small cell lung cancer with acquired resistance: circulating tumor DNA and angiogenesis markers.
Liu Meng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.